Search results
Results from the WOW.Com Content Network
Microsoft Intune (formerly Microsoft Endpoint Manager and Windows Intune) is a Microsoft cloud-based unified endpoint management service for both corporate and BYOD devices. [2] It extends some of the "on-premises" functionality of Microsoft Configuration Manager to the Microsoft Azure cloud.
Microsoft family features (includes family safety features formerly known as Microsoft Family Safety, formerly Parental Controls in Windows 7 and Vista) is a free set of features available on Windows 10 PC and Mobile that is bundled with the Windows 10, Home edition operating system.
At the time of launch, Microsoft deemed Windows 7 (with Service Pack 1) and Windows 8.1 users eligible to upgrade to Windows 10 free of charge, so long as the upgrade took place within one year of Windows 10's initial release date. Windows RT and the respective Enterprise editions of Windows 7, 8, and 8.1 were excluded from this offer.
Shortly after the suit was reported on by the Seattle Times, Microsoft confirmed it was updating the GWX software once again to add more explicit options for opting out of a free Windows 10 upgrade; [368] [369] [366] the final notification was a full-screen pop-up window notifying users of the impending end of the free upgrade offer, and ...
Mobile device management (MDM) is the administration of mobile devices, such as smartphones, tablet computers, and laptops.MDM is usually implemented with the use of a third-party product that has management features for particular vendors of mobile devices.
WASHINGTON (Reuters) -A U.S. appeals court on Thursday blocked the Federal Communications Commission's reinstatement of landmark net neutrality rules, saying broadband providers are likely to ...
In older versions of the copy software CloneCD, the features "Amplify Weak Sectors", "Protected PC Games," and "Hide CDR Media" were disabled in the United States and Japan. Changing the region and language settings in Windows (e.g., to Canadian English) or patches could unlock these features in the two countries.
(Reuters) -Regeneron Pharmaceuticals said on Monday the U.S. FDA has declined approval for its blood cancer therapy for two forms of lymphoma on concerns over the progress of ongoing confirmatory ...